News & Announcements

Washington University School of Medicine in St. Louis has established a Division of Physician-Scientists to help nurture the career development of physicians who want to conduct scientific research. The new division will be headed by Wayne M. Yokoyama, MD, the Sam J. Levin and Audrey Loew Levin Professor of Arthritis Research.

On June 14, 2019, the Shreiber Lab participated in Wear White for a Future.  By wearing white together, they are standing for science and the search for immune-based cures. Wear White Day is critical part of June’s Cancer Immunotherapy Month awareness and education programs. #Immune2Cancer

Chancellor Mark S. Wrighton lists Bob Schreiber’s work on immunological approaches to ­dealing with ­diseases, including cancer as an accomplishment that has made one of the biggest impact during his tenure.

Robert D. Schreiber, PhD, the Andrew M. and Jane M. Bursky Distinguished Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has been elected a fellow of the American Association for Cancer Research (AACR) Academy.

Ali Ellebedy, PhD (an assistant professor of pathology and immunology and a researcher with the Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs) and colleagues will compare how people’s immune systems respond to the yellow-fever vaccine and the inactivated flu vaccine to better understand how vaccines elicit long-lasting immune responses. In contrast to the flu vaccine, the yellow-fever vaccine provides robust life-long immunity.

Immune-based therapies are becoming a reality for cancer care. A few short decades ago, cancer treatment consisted mainly of three pillars: surgery, radiation and chemotherapy. Although each has earned its place as a valuable option, more precise alternatives have long been the oncologist’s dream.

Michael S. Diamond, MD, PhD, an infectious diseases specialist at Washington University School of Medicine in St. Louis, has been chosen as the recipient of the American Society for Clinical Investigation’s 2019 Stanley J. Korsmeyer Award. He is being honored for his contributions to understanding the molecular basis of disease caused by globally emerging RNA viruses such as the Zika, West Nile and chikungunya viruses.

Neuroscientist Azad Bonni, MD, PhD, and virologist and immunologist Michael S. Diamond, MD, PhD, both of Washington University School of Medicine in St. Louis, have been elected to the National Academy of Medicine, a part of the National Academy of Sciences. Membership in the organization is one of the highest honors in the fields of health and medicine in the United States.

Radiation oncologist Carl J. DeSelm, MD, PhD, has been honored by the National Institutes of Health (NIH) for his visionary research to harness the immune system to fight cancer.

Norman E. “Ned” Sharpless, MD, newly named director of the National Cancer Institute of the National Institutes of Health (NIH), speaks at a town hall Tuesday, Feb. 27, on the Medical Campus. He visited the School of Medicine to attend and speak at the Bursky Center symposium and participate in a town hall.